Vitamin Shoppe Company Profile (NYSE:VSI)

About Vitamin Shoppe (NYSE:VSI)

Vitamin Shoppe logoVitamin Shoppe, Inc. (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats. The direct segment sells its products directly to consumers through the Internet, primarily at The manufacturing segment provides custom manufacturing and private labeling of vitamin, mineral and supplement products, and develops and markets its own branded products for both sales to third parties and for the VSI product assortment. As of December 31, 2016, it marketed approximately 900 brands, as well as its own brands. As of December 31, 2016, it operated 775 stores located in 45 states, the District of Columbia and Puerto Rico, primarily located in retail centers and standalone locations.

Industry, Sector and Symbol:
  • Sector: Retail/Wholesale
  • Industry: Health Food Stores
  • Sub-Industry: Specialty Stores
  • Symbol: NYSE:VSI
  • CUSIP: 92849E10
  • Web:
  • Market Cap: $130.05 million
  • Outstanding Shares: 23,223,000
Average Prices:
  • 50 Day Moving Avg: $9.58
  • 200 Day Moving Avg: $15.16
  • 52 Week Range: $5.60 - $28.41
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 7.09
  • P/E Growth: -0.23
Sales & Book Value:
  • Annual Revenue: $1.24 billion
  • Price / Sales: 0.10
  • Book Value: $12.73 per share
  • Price / Book: 0.44
  • EBIDTA: $99.96 million
  • Net Margins: -11.98%
  • Return on Equity: 8.33%
  • Return on Assets: 4.92%
  • Debt-to-Equity Ratio: 0.42%
  • Current Ratio: 2.27%
  • Quick Ratio: 0.34%
  • Average Volume: 568,641 shs.
  • Beta: 0.68
  • Short Ratio: 11.37

Frequently Asked Questions for Vitamin Shoppe (NYSE:VSI)

What is Vitamin Shoppe's stock symbol?

Vitamin Shoppe trades on the New York Stock Exchange (NYSE) under the ticker symbol "VSI."

How were Vitamin Shoppe's earnings last quarter?

Vitamin Shoppe, Inc (NYSE:VSI) released its quarterly earnings results on Wednesday, August, 9th. The company reported $0.23 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.39 by $0.16. The firm earned $304.84 million during the quarter, compared to analyst estimates of $314.74 million. Vitamin Shoppe had a negative net margin of 11.98% and a positive return on equity of 8.33%. The business's revenue for the quarter was down 8.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.55 EPS. View Vitamin Shoppe's Earnings History.

When will Vitamin Shoppe make its next earnings announcement?

Vitamin Shoppe is scheduled to release their next quarterly earnings announcement on Tuesday, October, 31st 2017. View Earnings Estimates for Vitamin Shoppe.

Where is Vitamin Shoppe's stock going? Where will Vitamin Shoppe's stock price be in 2017?

7 brokerages have issued 12 month target prices for Vitamin Shoppe's stock. Their predictions range from $6.00 to $28.00. On average, they anticipate Vitamin Shoppe's stock price to reach $13.83 in the next twelve months. View Analyst Ratings for Vitamin Shoppe.

Who are some of Vitamin Shoppe's key competitors?

Who are Vitamin Shoppe's key executives?

Vitamin Shoppe's management team includes the folowing people:

  • Colin Frederick Watts, Chief Executive Officer, Director
  • Brenda M. Galgano CPA, Chief Financial Officer, Executive Vice President
  • Michael A. Jaffe, Interim General Counsel, Corporate Secretary
  • John D. Bowlin, Lead Independnt Director
  • B. Michael Michael Becker CPA, Independent Director
  • Deborah M. Derby, Independent Director
  • Tracy Dolgin, Independent Director
  • David H. Edwab CPA, Independent Director

Who owns Vitamin Shoppe stock?

Vitamin Shoppe's stock is owned by many different of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (8.66%), Eagle Asset Management Inc. (6.61%), Vanguard Group Inc. (5.83%), FMR LLC (5.42%), CARLSON CAPITAL L P (4.97%) and State Street Corp (2.66%). Company insiders that own Vitamin Shoppe stock include B Michael Becker, Dan Lamadrid, Guillermo Marmol and Richard L Markee. View Institutional Ownership Trends for Vitamin Shoppe.

Who sold Vitamin Shoppe stock? Who is selling Vitamin Shoppe stock?

Vitamin Shoppe's stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Eagle Asset Management Inc., Ameriprise Financial Inc., State Street Corp, Menta Capital LLC, Wells Fargo & Company MN, Prudential Financial Inc. and Thrivent Financial For Lutherans. Company insiders that have sold Vitamin Shoppe stock in the last year include B Michael Becker, Dan Lamadrid and Richard L Markee. View Insider Buying and Selling for Vitamin Shoppe.

Who bought Vitamin Shoppe stock? Who is buying Vitamin Shoppe stock?

Vitamin Shoppe's stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Canada Pension Plan Investment Board, Los Angeles Capital Management & Equity Research Inc., Schwab Charles Investment Management Inc., Financial & Investment Management Group Ltd., Goldman Sachs Group Inc., Parametric Portfolio Associates LLC and Systematic Financial Management LP. View Insider Buying and Selling for Vitamin Shoppe.

How do I buy Vitamin Shoppe stock?

Shares of Vitamin Shoppe can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vitamin Shoppe's stock price today?

One share of Vitamin Shoppe stock can currently be purchased for approximately $5.60.

MarketBeat Community Rating for Vitamin Shoppe (NYSE VSI)
Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  172 (Vote Outperform)
Underperform Votes:  330 (Vote Underperform)
Total Votes:  502
MarketBeat's community ratings are surveys of what our community members think about Vitamin Shoppe and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Vitamin Shoppe (NYSE:VSI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 6 Hold Ratings
Consensus Rating:Hold (Score: 1.86)
Consensus Price Target: $13.83 (147.02% upside)

Analysts' Ratings History for Vitamin Shoppe (NYSE:VSI)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/10/2017Morgan StanleySet Price TargetHold$14.00 -> $8.00MediumView Rating Details
8/10/2017Goldman Sachs Group, Inc. (The)Reiterated RatingSell$13.00 -> $6.00MediumView Rating Details
8/10/2017Deutsche Bank AGReiterated RatingHold$14.00 -> $7.00HighView Rating Details
8/10/2017Barclays PLCLower Price TargetEqual Weight$13.00 -> $6.00HighView Rating Details
5/11/2017GabelliDowngradeBuy -> HoldMediumView Rating Details
10/27/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$33.00 -> $28.00N/AView Rating Details
9/26/2016Jefferies Group LLCReiterated RatingHold$28.00N/AView Rating Details
8/3/2016WedbushReiterated RatingOutperform$39.00N/AView Rating Details
5/16/2016Robert W. BairdReiterated RatingHoldN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingNeutralN/AView Rating Details
5/5/2016MacquarieReiterated RatingNeutral$40.00N/AView Rating Details
4/15/2016Piper Jaffray CompaniesReiterated RatingNeutral$30.00N/AView Rating Details
3/28/2016William BlairDowngradeMarket PerformN/AView Rating Details
12/13/2015Bank of America CorporationReiterated RatingUnderperform$26.00 -> $28.00N/AView Rating Details
(Data available from 8/22/2015 forward)


Earnings History for Vitamin Shoppe (NYSE:VSI)
Earnings by Quarter for Vitamin Shoppe (NYSE:VSI)
Earnings History by Quarter for Vitamin Shoppe (NYSE VSI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2017$0.18N/AView Earnings Details
8/9/2017Q2 2017$0.39$0.23$314.74 million$304.84 millionViewListenView Earnings Details
5/10/2017Q1 2017$0.58$0.37$325.71 million$316.90 millionViewN/AView Earnings Details
3/1/2017Q416$0.40$0.36$311.79 million$304.87 millionViewListenView Earnings Details
11/2/2016Q316$0.50$0.50$317.18 million$314.90 millionViewN/AView Earnings Details
8/3/2016Q216$0.59$0.55$331.58 million$332.70 millionViewN/AView Earnings Details
5/4/2016Q116$0.65$0.67$339.76 million$336.80 millionViewN/AView Earnings Details
2/23/2016Q415$0.38$0.39$294.17 million$293.50 millionViewListenView Earnings Details
11/4/2015Q315$0.47$0.52$317.28 million$313.90 millionViewN/AView Earnings Details
8/5/2015Q215$0.54$0.57$325.78 million$322.30 millionViewN/AView Earnings Details
5/6/2015Q115$0.74$0.63$344.66 million$336.80 millionViewN/AView Earnings Details
2/24/2015Q414$0.41$0.41$294.77 million$290.10 millionViewN/AView Earnings Details
11/4/2014Q314$0.52$0.40$314.60 million$308.90 millionViewN/AView Earnings Details
8/5/2014Q214$0.63$0.62$306.09 million$306.20 millionViewN/AView Earnings Details
5/7/2014Q114$0.68$0.67$302.82 million$307.80 millionViewN/AView Earnings Details
2/25/2014Q413$0.38$0.37$253.87 million$256.40 millionViewN/AView Earnings Details
11/5/2013Q313$0.52$0.53$273.87 million$272.50 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.60$0.60$284.28 million$279.50 millionViewListenView Earnings Details
5/7/2013Q1 2013$0.69$0.68$282.71 million$279.10 millionViewListenView Earnings Details
2/26/2013Q4 2012$0.40$0.40$223.88 million$218.90 millionViewListenView Earnings Details
11/6/2012Q312$0.46$0.54$234.66 million$239.00 millionViewN/AView Earnings Details
8/7/2012$0.51$0.55ViewN/AView Earnings Details
5/8/2012$0.57$0.61ViewN/AView Earnings Details
2/28/2012$0.32$0.38ViewN/AView Earnings Details
10/26/2011$0.33$0.41ViewN/AView Earnings Details
7/28/2011$0.38$0.40ViewN/AView Earnings Details
4/26/2011$0.40$0.47ViewN/AView Earnings Details
2/16/2011$0.21$0.22ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Vitamin Shoppe (NYSE:VSI)
2017 EPS Consensus Estimate: $2.40
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.75$0.79$0.77
Q2 20172$0.59$0.64$0.62
Q3 20172$0.53$0.57$0.55
Q4 20172$0.43$0.50$0.47
(Data provided by Zacks Investment Research)


Dividend History for Vitamin Shoppe (NYSE:VSI)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Vitamin Shoppe (NYSE:VSI)
Insider Ownership Percentage: 1.07%
Insider Trades by Quarter for Vitamin Shoppe (NYSE:VSI)
Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)
Insider Trades by Quarter for Vitamin Shoppe (NYSE:VSI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/8/2017B. Michael BeckerDirectorSell2,729$19.41$52,969.89View SEC Filing  
3/3/2017Dan LamadridCAOSell5,432$22.36$121,459.52View SEC Filing  
3/3/2017Richard L MarkeeDirectorSell100,000$22.24$2,224,000.00View SEC Filing  
11/8/2016Dan LamadridCAOSell1,734$23.20$40,228.80View SEC Filing  
5/31/2016Guillermo MarmolDirectorBuy1,000$30.23$30,230.00View SEC Filing  
11/14/2014Brenda GalganoCFOSell5,000$48.77$243,850.00View SEC Filing  
11/13/2014Richard L MarkeeInsiderSell27,774$47.79$1,327,319.46View SEC Filing  
9/18/2014Anthony N TruesdaleCEOSell61,792$45.00$2,780,640.00View SEC Filing  
9/18/2014Richard L MarkeeInsiderSell30,000$45.00$1,350,000.00View SEC Filing  
9/12/2014Jean W FrydmanInsiderSell1,135$43.40$49,259.00View SEC Filing  
6/16/2014Richard L MarkeeChairmanSell10,000$45.00$450,000.00View SEC Filing  
6/11/2014Anthony AlfonsoInsiderBuy5,000$44.44$222,200.00View SEC Filing  
5/1/2014Anthony TruesdaleCEOSell35,000$47.18$1,651,300.00View SEC Filing  
5/1/2014Richard MarkeeChairmanSell10,000$47.18$471,800.00View SEC Filing  
4/1/2014Anthony TruesdaleCEOSell35,000$47.91$1,676,850.00View SEC Filing  
4/1/2014Richard MarkeeInsiderSell10,000$47.91$479,100.00View SEC Filing  
3/3/2014Anthony TruesdaleCEOSell35,000$46.30$1,620,500.00View SEC Filing  
3/3/2014Richard MarkeeInsiderSell10,000$46.29$462,900.00View SEC Filing  
1/10/2014Anthony TruesdaleCEOSell35,000$48.51$1,697,850.00View SEC Filing  
11/14/2013Richard MarkeeChairmanSell50,000$52.48$2,624,000.00View SEC Filing  
11/13/2013David EdwabDirectorSell3,738$52.35$195,684.30View SEC Filing  
2/28/2013B. Michael BeckerDirectorBuy1,000$51.95$51,950.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Vitamin Shoppe (NYSE:VSI)
Latest Headlines for Vitamin Shoppe (NYSE:VSI)
DateHeadline logoVitamin Shoppe (VSI) Alert: Shareholder Rights Law Firm J&W Investigates Vitamin Shoppe, Inc.; Encourages Investors to Contact the Firm - August 18 at 8:37 AM logoHaeggquist & Eck Encourages Investors Who Suffered Losses Investing in Vitamin Shoppe, Inc. to Contact the Firm - August 17 at 9:08 AM logoZacks Investment Research Lowers Vitamin Shoppe, Inc (VSI) to Sell - August 15 at 2:02 PM logoThe Vitamin Shoppe Collaborates with Liquid Agency to Launch SPARK AUTO DELIVERY™ - August 15 at 8:07 AM logo$0.15 Earnings Per Share Expected for Vitamin Shoppe, Inc (NYSE:VSI) This Quarter - August 14 at 2:30 PM logoGabelli Equities Analysts Cut Earnings Estimates for Vitamin Shoppe, Inc (NYSE:VSI) - August 14 at 3:54 AM logoVitamin Shoppe, Inc (NYSE:VSI) Given Average Rating of "Hold" by Brokerages - August 11 at 6:48 PM logoVitamin Shoppe, Inc (NYSE:VSI) Cut to D at TheStreet - August 11 at 3:24 PM logoVitamin Shoppe, Inc (VSI) Receives Sell Rating from Goldman Sachs Group, Inc. (The) - August 10 at 8:28 PM logoVitamin Shoppe, Inc (VSI) Price Target Lowered to $8.00 at Morgan Stanley - August 10 at 7:02 PM logoVitamin Shoppe Shares Are Being Walloped By One of the Biggest Selling Waves You May Have Ever Seen - August 10 at 3:43 PM logoVitamin Shoppe falls to all-time low on earnings miss, lowered guidance - August 10 at 9:30 AM logoEdited Transcript of VSI earnings conference call or presentation 9-Aug-17 12:30pm GMT - August 10 at 9:30 AM logoVitamin Shoppe, Inc (NYSE:VSI) Posts Quarterly Earnings Results, Misses Expectations By $0.16 EPS - August 9 at 6:24 PM logoMid-Afternoon Market Update: Vitamin Shoppe Drops After Downbeat Q2 Results; Silver Spring Networks Shares Jump - August 9 at 3:52 PM logoWhy Vitamin Shoppe Stock Got Destroyed Today - August 9 at 3:35 PM logoVitamin Shoppe, Inc. Announces Second Quarter 2017 Results - August 9 at 9:00 AM logoVitamin Shoppe reports 2Q loss - August 9 at 9:00 AM logoCrave Crush Now Available Nationwide At The Vitamin Shoppe - August 8 at 8:11 AM logoRobert Olstein Buys Alphabet Inc, Apple Inc, Western Digital Corp, Sells Vitamin Shoppe Inc, ... - August 4 at 9:49 AM logoETFs with exposure to Vitamin Shoppe, Inc. : August 1, 2017 - August 2 at 8:33 AM logoVitamin Shoppe, Inc (NYSE:VSI) to Release Quarterly Earnings on Wednesday - August 2 at 7:22 AM logoVitamin Shoppe, Inc (VSI) Downgraded to "Sell" at BidaskClub - July 27 at 7:15 PM logoVitamin Shoppe, Inc (VSI) Expected to Post Earnings of $0.39 Per Share - July 27 at 11:17 AM logoThe Vitamin Shoppe Launches New Product Innovation With Healthy Natural Solutions - July 27 at 9:17 AM logoVitamin Shoppe, Inc. Announces Fiscal Second Quarter 2017 Earnings Release and Webcast Date - July 27 at 9:17 AM logoVitamin Shoppe, Inc (VSI) Scheduled to Post Earnings on Tuesday - July 25 at 7:32 AM logoVitamin Shoppe, Inc (VSI) Upgraded by Zacks Investment Research to "Hold" - July 18 at 11:59 AM logoVitamin Shoppe, Inc (VSI) Receives Consensus Rating of "Hold" from Brokerages - July 17 at 6:40 PM logoVitamin Shoppe (VSI) versus Natural Grocers by Vitamin Cottage (NGVC) Head-To-Head Comparison - July 13 at 10:23 PM logoFinancial Analysis: Natural Grocers by Vitamin Cottage (NGVC) & Vitamin Shoppe (NYSE:VSI) - July 13 at 8:09 AM logoETFs with exposure to Vitamin Shoppe, Inc. : July 7, 2017 - July 8 at 4:50 PM logoReviewing Vitamin Shoppe (NYSE:VSI) & Natural Grocers by Vitamin Cottage (NGVC) - July 8 at 12:16 AM logo$315.29 Million in Sales Expected for Vitamin Shoppe, Inc (VSI) This Quarter - July 5 at 11:50 AM logoZacks: Brokerages Expect Vitamin Shoppe, Inc (VSI) to Announce $0.39 Earnings Per Share - July 3 at 10:14 AM logoComparing Natural Grocers by Vitamin Cottage (NGVC) and Vitamin Shoppe (VSI) - June 29 at 10:32 PM logoHead to Head Review: Vitamin Shoppe (VSI) vs. Natural Grocers by Vitamin Cottage (NGVC) - June 28 at 6:28 PM logoFinancial Review: Vitamin Shoppe (VSI) & Natural Grocers by Vitamin Cottage (NGVC) - June 28 at 7:52 AM logoETFs with exposure to Vitamin Shoppe, Inc. : June 26, 2017 - June 26 at 8:35 PM logoReviewing Natural Grocers by Vitamin Cottage (NGVC) & Vitamin Shoppe (VSI) - June 25 at 7:36 AM logoVitamin Shoppe, Inc. :VSI-US: Earnings Analysis: Q1, 2017 By the Numbers : June 23, 2017 - June 24 at 7:49 AM logoVitamin Shoppe, Inc (VSI) Given Consensus Rating of "Hold" by Brokerages - June 20 at 4:14 PM logoBear of the Day: Vitamin Shoppe (VSI) - June 19 at 8:24 AM logoVitamin Shoppe (VSI) versus Natural Grocers by Vitamin Cottage (NGVC) Critical Contrast - June 18 at 12:42 AM logoReviewing Vitamin Shoppe (VSI) and Natural Grocers by Vitamin Cottage (NGVC) - June 17 at 10:26 PM logoVitamin Shoppe Inc (VSI) Expected to Post Quarterly Sales of $315.29 Million - June 9 at 4:04 PM logo Brokerages Anticipate Vitamin Shoppe Inc (VSI) Will Announce Earnings of $0.39 Per Share - June 7 at 8:06 AM logoForty Years of Thriving: The Vitamin Shoppe celebrates 40 years of health and wellness with a month-long celebration honoring its heritage and role as a leading omni-channel specialty retailer and lifestyle destination. - June 6 at 1:52 AM logoVitamin Shoppe Inc (VSI) Cut to "Hold" at ValuEngine - June 2 at 8:04 PM logoVitamin Shoppe Inc (VSI) Given Consensus Rating of "Hold" by Analysts - May 26 at 4:52 PM



Vitamin Shoppe (VSI) Chart for Tuesday, August, 22, 2017

This page was last updated on 8/22/2017 by Staff